Date : 09 February 2021
OTHERS METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY") - JOINT RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN METRONIC MEDICARE SDN. BHD., THE WHOLLY-OWNED SUBSIDIARY OF METRONIC AND JOYSBIO (TIANJIN) BIOTECHNOLOGY CO.,LTD
| METRONIC GLOBAL BERHAD |
| Type | Announcement |
| Subject | OTHERS |
| Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY")
- JOINT RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN METRONIC MEDICARE SDN. BHD., THE WHOLLY-OWNED SUBSIDIARY OF METRONIC AND JOYSBIO (TIANJIN) BIOTECHNOLOGY CO.,LTD |
|
Reference is made to the Company’s announcements dated 2 February 2021 and 4 February 2021 respectively.
The Board of Directors of Metronic wishes to inform that the company has received a periodical report from Joysbio (Tianjin) Biotechnology Co. Ltd., among others, that the results for the SARS-CoV-2 Neutralizing Antibody Test Kit was 100% accurate.
The Company, in pursuant to the above progress, has pursued for final test which to be conducted in Centrol Lab, Italy.
This announcement is dated 9 February 2021. |
|
Announcement Info
| Company Name | METRONIC GLOBAL BERHAD |
| Stock Name | MTRONIC |
| Date Announced | 09 Feb 2021 |
| Category | General Announcement for PLC |
| Reference Number | GA1-09022021-00074 |